WuXi opens continuous manufacturing line for oral solids
The CDMO announces the launch of its first drug product continuous manufacturing line for oral solids, located in Wuxi City, China.
The CDMO announces the launch of its first drug product continuous manufacturing line for oral solids, located in Wuxi City, China.
The company receives approval from Health Canada to import amoxicillin, as numerous countries struggle with shortages for the antibiotic.
On Friday (Jan 6), the US Food and Drink Administration (FDA) granted a licence for another anti-amyloid drug – lecanemab – to treat Alzheimer’s disease.
The newly launched biotech is looking to develop small molecule drugs using its photoaffinity-based chemoproteomics platform.